US Bans Russian Company Kaspersky's Software Over Security Concerns
Date
6/20/2024 9:15:09 PM
(MENAFN- IANS) Washington, June 21 (IANS/DPA) The US will ban the sale of antivirus software made by Moscow-based cybersecurity company Kaspersky.
The company's operations in the US presented a national security risk "due to the Russian government's offensive cyber capabilities and capacity to influence or direct Kaspersky's operations," the US Department of Commerce said in a statement on Thursday.
"Kaspersky will generally no longer be able to, among other activities, sell its software within the US or provide updates to software already in use."
Private and professional users of Kaspersky's widely installed antivirus software should find an alternative due to the risk, the Department added.
"Russia has shown time and again they have the capability and intent to exploit Russian companies, like Kaspersky Lab, to collect and weaponise sensitive US information, and we will continue to use every tool at our disposal to safeguard US national security and the American people," Secretary of Commerce Gina Raimondo said.
The sale of Kaspersky software in the US will be banned from July 20.
The Russian multinational will be able to provide software updates to existing users until September 29.
Kaspersky's software is designed to protect users against trojans, spyware and other cyber threats.
In the US, installation on government devices has been banned since 2017, and in Germany, the Federal Office for Information Security warns against using the software.
Kaspersky has denied its products pose a risk, stating it is a private global cybersecurity company with no ties to the Russian government.
MENAFN20062024000231011071ID1108355679
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.